Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

119
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
119
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

61
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
61
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

87
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
87
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

63
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
63
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

98
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
98
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

73
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
73

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reframing cancer cachexia: from malnutrition to treatable disease.

Nature reviews. Endocrinology·2026
Same author

Frailty Predicts Incident Osteoporotic Fractures in Veterans with Rheumatoid Arthritis.

Arthritis care & research·2026
Same author

Baseline Functional Performance Predicts Better Long-Term Self-Reported Physical Function After Auto-HSCT.

Journal of clinical medicine·2026
Same author

The Clinical Framework of Onco-Geri-Rheumatology: Integrating Aging Biology, Cancer Immunotherapy, and Autoimmune Disease Care.

Arthritis care & research·2026
Same author

Ghrelin Receptor Deletion or Pharmacological Inhibition Improves Muscle Function in Aging Male Mice.

Aging cell·2026
Same author

Pulmonary Nodules and Splenic Lesions as Rare Extraintestinal Manifestations of Crohn's Disease.

Cureus·2026

Related Experiment Video

Updated: Oct 11, 2025

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

1.0K

Left ventricular non-compaction cardiomyopathy automatic diagnosis using a deep learning approach.

Jesús M Rodríguez-de-Vera1, Gregorio Bernabé1, José M García1

  • 1Computer Engineering Department, University of Murcia, Murcia 30071 Spain.

Computer Methods and Programs in Biomedicine
|December 3, 2021
PubMed
Summary

A deep learning model accurately diagnoses left ventricular non-compaction (LVNC) by measuring trabecular volume percentage (VT%) from cardiac MRI. This AI tool offers objective and rapid analysis for this rare cardiomyopathy.

Keywords:
Convolutional neural networkDeep learningHyper-trabeculationLeft ventricular non-compactionMRI Image segmentation

More Related Videos

Retrospective Cardiac Gating with A Prototype Small-Animal X-ray Computed Tomograph
05:32

Retrospective Cardiac Gating with A Prototype Small-Animal X-ray Computed Tomograph

Published on: February 21, 2025

463
Displacement Analysis of Myocardial Mechanical Deformation DIAMOND Reveals Segmental Heterogeneity of Cardiac Function in Embryonic Zebrafish
09:15

Displacement Analysis of Myocardial Mechanical Deformation DIAMOND Reveals Segmental Heterogeneity of Cardiac Function in Embryonic Zebrafish

Published on: February 6, 2020

5.1K

Related Experiment Videos

Last Updated: Oct 11, 2025

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

1.0K
Retrospective Cardiac Gating with A Prototype Small-Animal X-ray Computed Tomograph
05:32

Retrospective Cardiac Gating with A Prototype Small-Animal X-ray Computed Tomograph

Published on: February 21, 2025

463
Displacement Analysis of Myocardial Mechanical Deformation DIAMOND Reveals Segmental Heterogeneity of Cardiac Function in Embryonic Zebrafish
09:15

Displacement Analysis of Myocardial Mechanical Deformation DIAMOND Reveals Segmental Heterogeneity of Cardiac Function in Embryonic Zebrafish

Published on: February 6, 2020

5.1K

Area of Science:

  • Cardiology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Left ventricular non-compaction (LVNC) is a rare cardiomyopathy characterized by excessive trabeculation.
  • Diagnosing LVNC often relies on the trabecular volume percentage (VT%) of the left ventricle.

Purpose of the Study:

  • To develop and validate a deep learning-based method for measuring VT% and diagnosing LVNC.
  • To assess the accuracy and clinical validity of the AI-driven diagnostic approach.

Main Methods:

  • A 2D U-Net deep learning model was trained on short-axis cardiac MRI scans from 277 patients.
  • The model segmented the left ventricle's cavity, external wall, and trabecular tissue.
  • VT% was computed from segmentations, and a threshold was used for diagnosis; 5-fold cross-validation and cardiologist review were performed.

Main Results:

  • The U-Net model achieved high segmentation accuracy (Dice coefficients: 0.96 for cavity, 0.89 for wall, 0.84 for trabeculae).
  • Cardiologists rated 99.5% of segmentations as clinically valid.
  • The AI diagnosis achieved an Area Under the ROC Curve of 0.94, with 87% accuracy, 93% sensitivity, and 80% specificity.

Conclusions:

  • Deep learning with U-Net effectively delineates cardiac structures on MRI for accurate LVNC diagnosis.
  • This AI solution enables objective, faster analysis, reducing errors and cardiologist workload.
  • The method facilitates definitive diagnosis of LVNC through precise hyper-trabeculation measurement.